Invention Grant
US07829577B2 Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
有权
（+） - 1,4-二氢-7 - [（3S，4S）-3-甲氧基-4-（甲基氨基）-1-吡咯烷基] -4-氧代-1-（2-噻唑基）-1 ，8-萘啶-3-羧酸
![Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid](/docs/US/2010-11-09/US07829577B2/abs.jpg.600x600.jpg)
- Patent Title: Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
- Patent Title (中): （+） - 1,4-二氢-7 - [（3S，4S）-3-甲氧基-4-（甲基氨基）-1-吡咯烷基] -4-氧代-1-（2-噻唑基）-1 ，8-萘啶-3-羧酸
-
Application No.: US11478765Application Date: 2006-06-29
-
Publication No.: US07829577B2Publication Date: 2010-11-09
- Inventor: Masaru Higaki , Satoshi Nakao
- Applicant: Masaru Higaki , Satoshi Nakao
- Applicant Address: JP US CA So. San Francisco
- Assignee: Dainippon Sumitomo Pharma Co., Ltd.,Sunesis Pharmaceuticals, Inc.
- Current Assignee: Dainippon Sumitomo Pharma Co., Ltd.,Sunesis Pharmaceuticals, Inc.
- Current Assignee Address: JP US CA So. San Francisco
- Agency: Jones Day
- Main IPC: A61K31/47
- IPC: A61K31/47
![Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid](/abs-image/US/2010/11/09/US07829577B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to SNS-595 and methods of treating cancer using the same.
Public/Granted literature
- US20060247267A1 SNS-595 and methods of using the same Public/Granted day:2006-11-02
Information query
